Blogs

Be the first person to recommend this.
https://www.diabeteseducator.org/event/COMMIT : register today: Contact J. Rhoulhac for FREE Registration Code for COMMIT: FL ADCES MEMBERS ONLY!! Great opportunity to learn DM Medications and Lifestyle Choices Management from Experts: 10.0 CEUs approved by ADCES for a Virtual 2 day program. Hope to " SEE" you on Nov. 5-6, 2021!! Jeanna Rhoulhac sfadelng@gmail.com ​
0 comments
1 person recommends this.
It’s that time of year when we have to put away the swimsuits and dust off the sweaters and joggers for apple picking and pumpkin spice sweets. We need to remember it’s ok to enjoy fall without overindulging. Here are a few fall reminders. Get Moving Exercise improves mood and enhances happiness. Try an early morning hike with friends which can lift our spirits and sets us up for a successful, productive day. Eat a Healthy diet Forming healthy nutritional habits involves taking small steps, as opposed to a major overhaul all at once. Keep it attainable by making simple healthy choices as often as you ...
0 comments
Be the first person to recommend this.
Tirzepatide: Gaining Ground in the Diabetes World Nebile Cayan, PharmD Candidate 2022 1 Keishla Chevere Espada, PharmD Candidate 2022 1 Abigail Henry, PGY1 Community-Based Pharmacy Resident 1 Kam Capoccia, Clinical Professor of Community Care 1 1 Western New England University College of Pharmacy and Health Sciences Background Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist being investigated for the treatment of type 2 diabetes and chronic weight management. Tirzepatide is also being studied as a potential treatment for nonalcoholic steatohepatitis. 1 ...
0 comments
Be the first person to recommend this.
2021 OKLAHOMA ADCES SYMPOSIUM Staying Current with Diabetes Care NOVEMBER 5, 2021 8AM-4:30PM This is a knowledge-based activity designed for individuals active in diabetes education, including, RNs, RDNs, Pharmacists, and other health care providers interested in staying informed on current practices of care for patients with diabetes and other related conditions Please see the following registration link for our upcoming OK event: https://www.diabeteseducator.org/event/OKCBNOV21
0 comments
Be the first person to recommend this.
Don’t miss ADCES’ final Advocacy Townhall of 2021! This event will take place on Tuesday, October 26 from 1:00-2:00pm CT/ 2:00-3:00pm ET/ 11-12pm PT. No registration required. We are pleased to welcome special guest, Dave Walton, the CEO of T1D Exchange . Learn how T1D Exchange’s data platform is driving meaningful research, innovation in treatment, prevention and striving for a cure. We also hope to provide participants with an opportunity to meet and say “hi” to ADCES’ new CEO, Matt Hornberger. Join us in welcoming Matt and the advocacy work that you are all doing to improve care for people with diabetes and those at risk for diabetes! Participants are ...
0 comments
Be the first person to recommend this.
Over the last year, I have had some patients express frustration with their insulin pumps (along with the many other challenges that they have faced with the recent pandemic). The many complaints include the typical battles with hyperglycemia following cannulas kinking, adhesive problems, and overnight pump malfunctions which lead many of them to have sleepless nights. I have recently taken a few patients off their insulin pumps and started them on multiple daily injections. Surprisingly, some of these patients have been on pump therapy so long that they have never utilized pre-filled insulin pens. Training patients on their new insulin programs has provided ...
3 comments
Be the first person to recommend this.
Upcoming: Targeting Inceptor for Diabetes Therapy Payton Waltz, PharmD PGY1 Pharmacy Resident Sullivan University College of Pharmacy and Health Sciences, Louisville, KY Welcome to the celebration for the 100 th year of insulin therapy! In 1921, Frederick Banting, Charles Best, and John MacLeod all played a hand at discovering the use of insulin therapy in patients with diabetes. 1 According to the National Diabetes Statistics Report of 2020, 10.5% of the U.S. population had diabetes and 34.5% were classified as patients with prediabetes. 2 This disease, affecting the insulin-producing islet cells of the pancreas, impacts a large percentage of this country’s ...
0 comments
Be the first person to recommend this.
Many of our patients are making up for lost time and traveling again. In case you’re getting travel questions, it can be helpful to review tips from the pump and CGM companies, as well as these travel tips from the CDC. https://www.cdc.gov/diabetes/library/features/traveling-with-diabetes.html What resources have been helpful to you? What are you hearing from your patients about their recent travel experiences?
1 comment
Be the first person to recommend this.
In a March 2021 Massachusetts General Hospital news release, reported by Health Day News, some positive results were reported concerning protection to newborns by maternal COVID- vaccine recipients. Report as follows: March 25, 2021 Pregnant Women Pass on COVID Vaccine Protection to Newborns In some good news to emerge from the coronavirus pandemic, new research shows that pregnant women and new breastfeeding moms have a strong immune response to COVID-19 vaccines and can transfer that immunity to their infants. The study included 131 women of reproductive age (84 pregnant, 31 lactating and 16 not pregnant) who received ...
1 comment
Be the first person to recommend this.
On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2022, which outlines the proposed Medicare payment rates for 2022 and addresses other provisions including updates to the Medicare Diabetes Prevention Program (MDPP) and the Medical Nutrition Therapy (MNT) benefit. The proposed changes will be finalized in early November 2021 and will apply to Medicare Part B services furnished on or after January 1, 2022. The proposed rule is open for comment through September 13, 2021. ADCES is conducting a full analysis of the proposed rule and will submit comments to CMS ...
0 comments
Be the first person to recommend this.
Centers for Medicare & Medicaid Services (CMS) have announced some adjustments to their CGM policy that will go into effect on July 18 th . Historically, Medicare required patients to test their blood sugar 4x/day to be a candidate for CGM. The new policy has removed all BG testing requirements. Patients still need to be taking insulin at least 3 times a day or using an insulin pump. Previously, the criteria only including insulin via injections, however, the new policy adds inhaled insulin to the approved methods of insulin delivery. The new policy can be found at https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?lcdid=33822 ...
1 comment
Be the first person to recommend this.
Can’t find a resource, need an answer to a burning question, looking to create a new education document….. Look no farther than the ADCES Connect site. This site gives you access to Communities of Interest and Practice Area Discussion list. Don’t reinvent the wheel with documents and educational needs. Reach out to a vast array of professional that are willing to share their knowledge, experiences, and documents to help you. Join as many areas as you want to get updates on what people are talking about and learn what others are doing in their institutions. This is a great way to connect with colleagues from other states and professions. So, what are you waiting ...
0 comments
Be the first person to recommend this.
Join the ADCES Advocacy Committee for their next Advocacy Townhall call on Tuesday, August 24 from 1:00-2:00pm CT/ 2:00-3:00pm ET/ 11-12pm PT. No registration required. Note, this meeting has been rescheduled from July 27. On this call, we'll be joined by representatives the College Diabetes Network who will be discussing their advocacy efforts and opportunities for collaboration. We’ll also discuss federal legislation, like the reintroduction of the Expanding Access to DSMT Act and bills to permanently expand telehealth, as well as recent updates to the Medicare clinical coverage criteria for CGMs and the Medicare Physician Fee Schedule proposed rule ...
0 comments
Be the first person to recommend this.
Hepatitis B Vaccine in Older Individuals with Type 2 Diabetes Lourdes Cross, PharmD, BCACP, CDCES Key Takeaways HBsAg/CpG (Heplisav-B) is a single-antigen hepatitis B vaccine with a immunostimulatory sequence adjuvant administered as 2 doses, 1 month apart. HBsAg/CpG provides higher rates of seroprotection against hepatitis B virus versus 3-dose HBsAg/alum (Engerix-B) in patients aged 60-70 years with type 2 diabetes. Adverse events and deaths are comparable in both groups. Introduction Although hepatitis B is a vaccine-preventable disease, hepatitis B virus (HBV) infection remains a major public health issue. Adults with diabetes are at ...
0 comments
Be the first person to recommend this.
With the nice weather in Western PA many of us are enjoying the long-awaited engagement in OUTDOOR activities. Listed are a few related self-management bits for people with diabetes. Make sure to scrub the skin well 3 times with alcohol wipe before applying a sensor or infusion set. Oily skin, dry skin or sweat can cause adhesion loss of the tape. Use an over patch or medical tape on your sensor to help keep the sensor on (even if not usually needed). Get a waterproof case to store your pump in for when you need to take it off to go swimming. If it is very hot, throw the entire case into the cooler that holds your food so it doesn't overheat in the ...
0 comments
Be the first person to recommend this.
As we have been made aware, diabetes is a global issue with approximately 34.2 million people in the US alone that have diabetes with about 7 million people undiagnosed. There are also approximately 88 million people who have prediabetes. By 2050 it is estimated that about 1 out of every 3 Americans will be diagnosed with Type 2 diabetes. Knowing that a diabetes diagnosis is only going to increase in the US, especially where food is very accessible and not always the healthier options, we as diabetes educators should be working on adding some additional strategies to help these patients. One such option would be to consider a plant-based diet. This lifestyle ...
0 comments
1 person recommends this.
Stop the Madness of Glucocorticoid-Induced Hyperglycemia! A Brief Review Steven Perzanowski, PharmD Candidate 2021 1 Alicia Len, PharmD Candidate 2021 1 Kam Capoccia, PharmD, BCPS, CDCES, Professor of Community Care 1 1 Western New England University College of Pharmacy and Health Sciences Incidence Glucocorticoids have many indications for both acute and chronic disease states and are associated with increased risk for glucocorticoid-induced hyperglycemia in people with and without diabetes. It’s estimated that about 40%-50% of all inpatient consults to endocrinology service are for new or worsening diabetes caused by glucocorticoid initiation. 1 ...
1 comment
Be the first person to recommend this.
Is Weight Bias and Weight Stigma a Public Health Problem? Megrette Fletcher M.Ed., RDN, CDCES In 2005, Dianne Neumark-Sztainer asked, " Can we simultaneously work toward the prevention of obesity and eating disorders in children and adolescents? " She noted weight-related issues are not in isolation. Ten years ago, Eric Stice , Ph.D., C. Nathan Marti , Ph.D., and Shelley Durant , B.S. concluded, "There is a growing body of scholarship that acknowledges that these weight-related domains are in fact related: obesity and eating disorders co-occur in individuals and have risk factors in common." ( Stice, et al., 2011 ) What are these commonalities? This ...
1 comment
1 person recommends this.
Once Weekly Insulin Icodec Article Review Austin Rich, PharmD, Sullivan University College of Pharmacy & Health Sciences In an article by Julio Rosenstock, et al, published in the New England Journal of Medicine on September 22, 2020, results of a phase 2 clinical trial comparing weekly insulin icodec to daily insulin glargine were reported. The goal of this study was to investigate the efficacy and safety of insulin icodec weekly injections compared to insulin glargine daily injections for initial insulin therapy in patients with type two diabetes mellitus (T2DM). There was a total of 247 participants included in the trial. Key inclusion criteria include ...
0 comments
Be the first person to recommend this.
Please find the PPT summary of the April AP CPI Journal Club April 27, 2021 April_JC_Slides.pptx Journal Article: Reducing the need for carbohydrate counting in type1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial Authors: Ahmad Haidar PhD | Jean-Francois Yale MD| Leif Erik Lovblom MSc | Nancy Cardinez NP | Andrej Orszag MD| C. Marcelo Falappa MD | Nikita Gouchie-Provencher RN | Michael A. Tsoukas MD | Anas El Fathi PhD | Jennifer Rene RN | Devrim Eldelekli BM | Sebastien O. Lanctôt | Daniel Scarr BSc | Bruce ...
0 comments